Work

Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma

Year: 2015

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/cgt.2015.60

Authors: Amudhan Pugalenthi, Kelly Mojica, Justin W Ady, Clark Johnsen, Damon Love, Nanhai G Chen, Richard J Aguilar, Aladar A Szalay, Yuman Fong

Institutions: Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, University of California San Diego, Genelux (United States), Beckman Research Institute, Moores Cancer Center, University of Würzburg

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Susan G. Komen for the Cure, Flight Attendant Medical Research Institute, Memorial Sloan-Kettering Cancer Center

Awards: G4620899001, G5089473966

OpenAlex ID: W2471866798

FWCI: 1.034

Cites: 37

Cited by: 22

Related to: 10